REGULATED PRESS RELEASE published on 10/26/2023 at 17:45, 2 years 10 months ago Third-quarter 2023 revenue of €1,286 million, up 13% like-for-like
REGULATED PRESS RELEASE published on 10/26/2023 at 17:45, 2 years 10 months ago Chiffre d’affaires du T3 2023 : 1 286 millions d’euros, +13% en données comparables
REGULATED PRESS RELEASE published on 10/26/2023 at 17:45, 2 years 10 months ago Manitou Group : Chiffre d’affaires du 3ème trimestre 2023
REGULATED PRESS RELEASE published on 10/26/2023 at 17:45, 2 years 10 months ago Manitou Group: Q3 2023 Revenues
REGULATED PRESS RELEASE published on 10/26/2023 at 17:41, 2 years 10 months ago Q3 FINANCIAL INFORMATION
REGULATED PRESS RELEASE published on 10/26/2023 at 17:41, 2 years 10 months ago T3 INFORMATION FINANCIERE
REGULATED PRESS RELEASE published on 10/26/2023 at 17:40, 2 years 10 months ago ALTEN : activité à fin septembre 2023
REGULATED PRESS RELEASE published on 10/26/2023 at 17:40, 2 years 10 months ago Eiffage réalise, en groupement avec Lorraine Énergie et DEF, les travaux du macro-lot technique pour la restauration de la cathédrale Notre-Dame de Paris
REGULATED PRESS RELEASE published on 10/26/2023 at 17:40, 2 years 10 months ago Eiffage, in consortium with Lorraine Énergie and DEF, carries out the work of the technical macro-lot for the restoration of Notre-Dame de Paris Cathedral
REGULATED PRESS RELEASE published on 10/26/2023 at 17:40, 2 years 10 months ago ALTEN: business at the end of September 2023
Published on 09/11/2026 at 04:00, 7 hours 56 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 31 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 36 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 56 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 13 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 21 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 26 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 1 hour 41 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 4 hours 56 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 4 hours 56 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 56 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 26 minutes ago Availability of the 2026 Interim Financial Report